The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells
Takeshi Itoh(Kyoto University), Shin Kaneko(Kyoto University)
Cited by 28
Related Papers
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
|Nature Communications|2021|209
Improved anti‐solid tumor response by humanized anti‐podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model
|Genes to Cells|2022|29
A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating cellular metabolism
|Communications Biology|2024|6